Protalix BioTherapeutics (NYSE:PLX) Stock Rating Lowered by StockNews.com
StockNews.com lowered shares of Protalix BioTherapeutics (NYSE:PLX – Free Report) from a strong-buy rating to a buy rating in a research note issued to investors on Monday morning. Separately, HC Wainwright increased their price objective on shares of Protalix BioTherapeutics from $10.00 to $15.00 and gave the company a “buy” rating in a research note […]
StockNews.com lowered shares of Protalix BioTherapeutics (NYSE:PLX – Free Report) from a strong-buy rating to a buy rating in a research note issued to investors on Monday morning. Separately, HC Wainwright increased their price objective on shares of Protalix BioTherapeutics from $10.00 to $15.00 and gave the company a “buy” rating in a research note […]
